Chalfont St. Giles, England 4/16/07—GE Healthcare has acquired Wave Biotech, a supplier of disposable manufacturing technologies, including the Wave bioreactor, Wave Mixer and Sterile Tube Fuser. Financial details were not disclosed. Based in Somerset, New Jersey, with approximately 70 employees, Wave Biotech has annual revenues of $25 million and its equipment is used at over […]

Following up on IBO’s examination of manufacturing trends in the industry (see IBO 3/31/07), Singapore continues to be a popular location for manufacturing facilities. This February, Fluidigm launched a Biomedical Product Development Center in Singapore, which will be used for R&D of a new biochip fluorescence reader and biochip loader. Bio-Rad unveiled a 20,000 square […]

Secondary ion mass spectrometry (SIMS) is an important surface science technique that provides very high sensitivity for the detection of trace elements in solid samples, while also providing good spatial detail. The physical process involved in SIMS is similar to that of other surface analyzer techniques: the sample’s surface is probed with a highly collimated […]

KBC Private Equity acquired a 75% stake in bioinformatics company Applied Maths NV in 2006. SAS and Ingenuity Systems integrated their respective JMP Genomics and Pathways Analysis solutions. Ingenuity Systems partnered with Compendia Bioscience, a provider of cancer profiling data and analysis tools, to integrate their respective Oncomine Professional and Pathways Analysis solutions. Thermo Fisher […]

Metrohm introduced the Process Lab, which can be customer configured. It combines analytical modules, such as pH, redox, conductivity and titration, and allows for the integration of third-party equipment. Brimrose launched the inline Luminar 4030 Miniature Free Space Process AOTF-NIR analyzer. Endress+Hauser introduced the Oxymax W COS21D series of digital dissolved oxygen (DO) sensors. Thermo […]

Santa Clara, CA 3/16/07; 4/25/07—As part of its first quarter earnings announcement, Symyx Technologies stated that due to market changes it is lowering its 2007 guidance and changing its business model. The company lowered its guidance for 2007 revenues from $133–$140 million, made in February, to $110–$120 million, and its guidance for net income from […]

Sequenom and QIAGEN GmbH entered into a strategic collaboration to jointly develop a preanalytical solution for small molecule (fetal) DNA enrichment for prenatal diagnostics. Sequenom will retain exclusive distribution rights to the technology for enriching short nucleic acids. In February, Sequenom named Steven Owings to the newly created position of vice president of Commercial Development, […]

Functional Genomics in Norway (FUGE), which was established in 2002 to build a knowledge base and infrastructure that would help Norway to work at the frontiers of functional genomics research has announced a budget of NOK 920 million ($154.4 million) for 2007–2011, of which NOK 420 million ($70.5 million) is now available for funding projects. […]